CSA Medical, Inc. is a company that develops and manufactures the RejuvenAir System, a unique cryotherapy system that uses liquid nitrogen spray to freeze and destroy damaged cells in the airways. This system promotes healing and is approved in the EU, with ongoing clinical investigations in the United States. For more information, visit www.rejuvenair.com or www.clinicaltrials.gov.